Sutherland Everett Rand bought KRYS
September 14, 2026 · Form 4 insider transaction
Sutherland Everett Rand bought 1,187 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,187
Price
$0.00
Total value
N/A
InsiderSutherland Everett Rand
RoleOfficer, Director
CompanyKrystal Biotech, Inc. (KRYS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 14, 2026
Filing dateSeptember 16, 2026
Shares owned after1,187
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant.